Literature DB >> 36088617

Successful left hepatic trisectionectomy after portal vein embolization for colon cancer liver metastasis in a patient with right-sided ligamentum teres.

Takeshi Urade1, Masahiro Kido2, Kaori Kuramitsu2, Shohei Komatsu2, Takuya Mizumoto2, Eisuke Ueshima3, Koji Sasaki3, Hiroaki Yanagimoto2, Hirochika Toyama2, Takumi Fukumoto2.   

Abstract

Right-sided ligamentum teres (RSLT) is a rare congenital anomaly in which the fetal umbilical vein is connected to the right paramedian trunk of the portal vein. An 80-year-old woman underwent curative sigmoidectomy for sigmoid cancer 3 years prior to presentation. After 1 year, small solitary liver metastasis was noted in segment 4. Because the patient experienced recurrence of the same lesion after chemotherapy and radiofrequency ablation, she was referred to our hospital. CT revealed an anomaly of the liver with RSLT, classified as an independent posterior branch type. The tumor in the left paramedian section was located in the right umbilical portion (RUP), and BDTT was advanced to the common bile duct. Because the estimated future remnant liver volume was 35.2%, transileocecal portal vein embolization (PVE) for the portal branches from the RUP increased it to 43.5% in 3 weeks. Left trisectionectomy with extrahepatic bile duct resection and hepaticojejunostomy were performed. The patient was discharged on postoperative day 75. We successfully performed a left trisectionectomy after PVE in a patient with RSLT. Understanding the vascular and biliary anomalies of patients with RSLT is essential. When the future remnant liver is small, PVE can be considered for safe hepatectomy.
© 2022. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Bile duct tumor thrombus; Colorectal liver metastasis; Hepatectomy; Portal vein embolization; Right-sided ligamentum teres

Year:  2022        PMID: 36088617     DOI: 10.1007/s12328-022-01698-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  1 in total

1.  Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor.

Authors:  Tomoyuki Abe; Kiyoshi Kajiyama; Norifumi Harimoto; Tomonobu Gion; Ken Shirabe; Takashi Nagaie
Journal:  Int J Surg Case Rep       Date:  2012-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.